NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
17
VERA Quote, Financials, Valuation and Earnings
Last price:
$42.26
Seasonality move
:
28.97%
Day range:
$40.96 - $45.06
52-week range:
$14.20 - $51.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
9.31x
Volume:
2.2M
Avg. volume:
588.3K
1-year change:
179.66%
Market cap:
$2.7B
Revenue:
--
EPS (TTM):
-$2.61
Earnings Data
Next earnings date for VERA
May 09
2025
Most recent earnings per share
-$0.85
Missed by $0.24
(Nov 7/2024)
Consensus Estimate
-$0.61
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VERA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | -- | -- | -- | -$0.73 | -- |
| 11/07/2024 | Q3 | -- | -- | -$0.85 | -$0.61 | -$0.24 |
| 08/08/2024 | Q2 | -- | -- | -$0.62 | -$0.54 | -$0.08 |
| 05/09/2024 | Q1 | -- | -- | -$0.56 | -$0.54 | -$0.02 |
| 03/28/2024 | Q4 | -- | -- | -$0.58 | -$0.51 | -$0.07 |
| 11/09/2023 | Q3 | -- | -- | -$0.45 | -$0.54 | $0.09 |
| 08/10/2023 | Q2 | -- | -- | -$0.46 | -$0.74 | $0.28 |
| 05/11/2023 | Q1 | -- | -- | -$0.80 | -$0.45 | -$0.35 |
| 03/28/2023 | Q4 | -- | -- | -$1.19 | -$0.90 | -$0.29 |
| 11/09/2022 | Q3 | -- | -- | -$0.91 | -$0.90 | -$0.01 |
| 08/10/2022 | Q2 | -- | -- | -$0.55 | -$0.78 | $0.23 |
| 05/16/2022 | Q1 | -- | -- | -$0.71 | -- | -- |
| 03/24/2022 | Q4 | -- | -- | -$0.79 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.36 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$0.33 | -- | -- |
| 06/24/2021 | Q1 | -- | -- | -$0.23 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$10.52 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$1.09 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.61 | -- | -- |
Vera Therapeutics Earnings Questions
-
How Much did Vera Therapeutics Generate in Revenue Last Quarter?
Vera Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Vera Therapeutics Beat Earnings Last Quarter?
Vera Therapeutics announced earnings per share of -$0.85 which represents a miss of analyst forecast a -$0.61 per share.
-
Is Vera Therapeutics Profitable?
Vera Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Vera Therapeutics EPS Next Year?
Vera Therapeutics's earnings are forecast to decrease from -$2.25 per share to -$2.18 per share next year representing a decrease of -19.85%.
-
When is Vera Therapeutics's Earnings Date?
Vera Therapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.65% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 4.9% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.4% over the past day.
